CITADEL ADVISORS LLC - Feb 14, 2025 Form SCHEDULE 13G Schedule Report for Aardvark Therapeutics, Inc. (AARD)

Filing Manager
CITADEL ADVISORS LLC
Reporting Manager
Kenneth Griffin
Security
Aardvark Therapeutics, Inc. Common Stock, par value $0.00001 per share (the "Shares")
Symbol
AARD
Shares outstanding
21.3M shares
Disclosed Ownership
1.19M shares
Ownership
5.6%
Form type
SCHEDULE 13G
Date filed
2/24/2025, 05:55 PM
Date of event
Feb 14, 2025
SEC
View on sec.gov

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Citadel Advisors LLC 5.4% 1.15M 0 1.15M /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Advisors Holdings LP 5.4% 1.15M 0 1.15M /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel GP LLC 5.4% 1.15M 0 1.15M /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities LLC 0.2% 40.6K 0 40.6K /s/ Guy Miller Guy Miller, Authorized Signatory
Citadel Securities Group LP 0.2% 40.6K 0 40.6K /s/ Guy Miller Guy Miller, Authorized Signatory
Citadel Securities GP LLC 0.2% 40.6K 0 40.6K /s/ Guy Miller Guy Miller, Authorized Signatory
Kenneth Griffin 5.6% 1.19M 0 1.19M /s/ Seth Levy Seth Levy, attorney-in-fact*